Literature DB >> 2841582

In vitro excision of adeno-associated virus DNA from recombinant plasmids: isolation of an enzyme fraction from HeLa cells that cleaves DNA at poly(G) sequences.

J Gottlieb1, N Muzyczka.   

Abstract

When circular recombinant plasmids containing adeno-associated virus (AAV) DNA sequences are transfected into human cells, the AAV provirus is rescued. Using these circular AAV plasmids as substrates, we isolated an enzyme fraction from HeLa cell nuclear extracts that excises intact AAV DNA in vitro from vector DNA and produces linear DNA products. The recognition signal for the enzyme is a polypurine-polypyrimidine sequence which is at least 9 residues long and rich in G.C base pairs. Such sequences are present in AAV recombinant plasmids as part of the first 15 base pairs of the AAV terminal repeat and in some cases as the result of cloning the AAV genome by G.C tailing. The isolated enzyme fraction does not have significant endonucleolytic activity on single-stranded or double-stranded DNA. Plasmid DNA that is transfected into tissue culture cells is cleaved in vivo to produce a pattern of DNA fragments similar to that seen with purified enzyme in vitro. The activity has been called endo R for rescue, and its behavior suggests that it may have a role in recombination of cellular chromosomes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841582      PMCID: PMC363452          DOI: 10.1128/mcb.8.6.2513-2522.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES.

Authors:  R W ATCHISON; B C CASTO; W M HAMMON
Journal:  Science       Date:  1965-08-13       Impact factor: 47.728

2.  Establishment and characterization of KB cell lines latently infected with adeno-associated virus type 1.

Authors:  H Handa; K Shiroki; H Shimojo
Journal:  Virology       Date:  1977-10-01       Impact factor: 3.616

3.  A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication.

Authors:  R J Samulski; L S Chang; T Shenk
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Variable number of tandem repeat (VNTR) markers for human gene mapping.

Authors:  Y Nakamura; M Leppert; P O'Connell; R Wolff; T Holm; M Culver; C Martin; E Fujimoto; M Hoff; E Kumlin
Journal:  Science       Date:  1987-03-27       Impact factor: 47.728

5.  Human homologs of TU transposon sequences: polypurine/polypyrimidine sequence elements that can alter DNA conformation in vitro and in vivo.

Authors:  B Hoffman-Liebermann; D Liebermann; A Troutt; L H Kedes; S N Cohen
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

6.  Latent infection of KB cells with adeno-associated virus type 2.

Authors:  C A Laughlin; C B Cardellichio; H C Coon
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

7.  Sequence-dependent S1 nuclease hypersensitivity of a heteronomous DNA duplex.

Authors:  T Evans; A Efstratiadis
Journal:  J Biol Chem       Date:  1986-11-05       Impact factor: 5.157

8.  Construction and characterization of new cloning vehicles. II. A multipurpose cloning system.

Authors:  F Bolivar; R L Rodriguez; P J Greene; M C Betlach; H L Heyneker; H W Boyer; J H Crosa; S Falkow
Journal:  Gene       Date:  1977       Impact factor: 3.688

9.  Adeno-associated virus general transduction vectors: analysis of proviral structures.

Authors:  S K McLaughlin; P Collis; P L Hermonat; N Muzyczka
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

10.  Endonuclease G: a (dG)n X (dC)n-specific DNase from higher eukaryotes.

Authors:  A Ruiz-Carrillo; J Renaud
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

View more
  15 in total

Review 1.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

2.  Both excision and replication of cloned autonomous parvovirus DNA require the NS1 (rep) protein.

Authors:  S L Rhode
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

3.  Origin of adeno-associated virus DNA replication is a target of carcinogen-inducible DNA amplification.

Authors:  A O Yalkinoglu; H Zentgraf; U Hübscher
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.

Authors:  X S Wang; S Ponnazhagan; A Srivastava
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats.

Authors:  X S Wang; K Qing; S Ponnazhagan; A Srivastava
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome.

Authors:  C Balagúe; M Kalla; W W Zhang
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Rescue of the adeno-associated virus genome from a plasmid vector: evidence for rescue by replication.

Authors:  Peter Ward; Per Elias; R Michael Linden
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  The herpes simplex virus 1 segment inversion site is specifically cleaved by a virus-induced nuclear endonuclease.

Authors:  F Wohlrab; S Chatterjee; R D Wells
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

9.  Adeno-associated virus DNA replication in vitro: activation by a maltose binding protein/Rep 68 fusion protein.

Authors:  P Ward; E Urcelay; R Kotin; B Safer; K I Berns
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  In vitro replication of adeno-associated virus DNA.

Authors:  T H Ni; X Zhou; D M McCarty; I Zolotukhin; N Muzyczka
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.